Relevance of short-term variation of B-type natriuretic peptide in patients with clinically stable heart failure

Wiener Klinische Wochenschrift

Volumn 120, Issue 21-22, 2008, Pages 672-678

  Maeder, Micha Tobias ^a,c   Hack, Dietrich ^a   Rickli, Hans ^a   Rocca, Hans Peter Brunner La ^b   Riesen, Walter ^a   Ammann, Peter ^a  

^a CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Heart failure; Hospitalization; Natriuretic peptide; Prognosis; Variation

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HOSPITAL READMISSION; HUMAN; MALE; MEAN ARTERIAL PRESSURE; SYSTOLIC HEART FAILURE; BLOOD; HEART FAILURE; MIDDLE AGED; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STATISTICS; TIME;

AGED; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STATISTICS AS TOPIC; TIME FACTORS;

EID: 58149286540     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00508-008-1099-x     Document Type: Article

References (28)

1. P De Groote J Dagorn B Soudan N Lamblin E McFadden C Bauters 2004 B-type natriuretic peptide and peak exercise oxygen consumption provide independent prognostic information for risk stratification in patients with stable congestive heart failure J Am Coll Cardiol 43 1584 1589
2. I Anand LD Fisher YT Chiang R Latini S Masson AP Maggioni 2003 Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT) Circulation 107 1278 1283
3. DR Murdoch TA McDonagh J Byrne L Blue R Farmer JJ Morton 1999 Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentrations: randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy Am Heart J 138 1126 1132
4. P Jourdain G Jondeau F Funck P Gueffet A LeHelloco E Donal 2007 Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study J Am Coll Cardiol 49 1733 1739
5. RW Troughton CM Frampton TG Yandle EA Espiner MG Nicholls AM Richards 2000 Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations Lancet 355 1126 1130
6. HP Brunner-La Rocca PT Buser R Schindler A Bernheim P Rickenbacher M Pfisterer 2006 Management of elderly patients with congestive heart failure - design of the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF) Am Heart J 151 949 955
7. S Bruins MR Fokkema JWP Romer MJ Dejongste FP van der Dijs JM van den Ouweland 2004 High intraindividual variation of B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with stable chronic heart failure Clin Chem 50 2052 2058
8. R O'Hanlon P O'Shea M Ledwidge C O'Loughlin S Lange C Conlon 2007 The biologic variability of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide in stable heart failure patients J Card Fail 13 50 55
9. AH Wu A Smith S Wieczorek JF Mather B Duncan CM White 2003 Biological variation for N-terminal pro- and B-type natriuretic peptide and implications for therapeutic monitoring of patients with congestive heart failure Am J Cardiol 92 628 631
10. AHB Wu 2006 Serial testing of B-type natriuretic peptide and NTpro-BNP for monitoring therapy of heart failure: the role of biologic variation in the interpretation of data Am Heart J 152 828 834
11. M Schou F Gustafsson PH Nielsen LH Madsen A Kjaer PR Hildebrand 2007 Unexplained week-to-week variation in BNP and NT-proBNP is low in chronic heart failure patients during steady state Eur J Heart Fail 9 68 74
12. A Clerico GC Zuccelli A Pilo M Emdin 2005 Clinical relevance of biological variation of B-type natriuretic peptide Clin Chem 51 925 926
13. T Tsutamoto A Wada H Sakai C Ishikawa T Tanaka M Hayashi 2006 Relationship between renal function and plasma brain natriuretic peptide in patients with heart failure J Am Coll Cardiol 47 582 586
14. SR Das MH Drazner DL Dries GL Vega HF Stanek SM Abdullah 2005 Impact of body mass and body composition on circulating levels of natriuretic peptides: results from the Dallas Heart Study Circulation 112 2163 2168
15. C Wold Knudsen H Vik-Mo T Omland 2005 Blood hemoglobin is an independent predictor of B-type natriuretic peptide (BNP) Clin Sci (Lond) 109 69 74
16. M Schultz J Faber C Kistorp A Jarlov F Pedersen N Wiinberg 2004 N-terminal pro-B-type natriuretic peptide (NT-pro-BNP) in different thyroid function states Clin Endocrinol (Oxf) 60 54 59
17. M Maeder P Ammann W Kiowski H Rickli 2005 B-type natriuretic peptide in patients with sepsis and preserved left ventricular ejection fraction Eur J Heart Fail 7 1164 1167
18. M Maeder T Wolber H Rickli J Myers D Hack W Riesen 2007 B-type natriuretic peptide kinetics and cardiopulmonary exercise testing in heart failure Int J Cardiol 120 391 398
19. K Swedberg J Cleland H Dargie H Drexler F Follath M Komajda 2005 Task Force of the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology (2005) Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology Eur Heart J 26 1115 1140
20. DW Cockcroft MH Gault 1976 Prediction of creatinine clearance from serum creatinine Nephron 16 31 41
21. Y Iwanaga I Nishi S Furuichi T Noguchi K Sase Y Kihara 2006 B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure J Am Coll Cardiol 47 742 748
22. C Passino AM Sironi B Favilli R Poletti C Prontera A Ripoli 2005 Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure Int J Cardiol 104 39 45
23. P Forfia SP Watkins JE Rame KJ Stewart EP Shapiro 2005 Relationship between B-type natriuretic peptides and pulmonary capillary wedge pressure in the intensive care unit J Am Coll Cardiol 45 1667 1671
24. JO O'Neill CE Bott-Silverman AT McRae 3rd RW Troughton K Ng RC Starling 2005 B-type natriuretic peptide levels are not a surrogate marker for invasive hemodynamics during management of patients with severe heart failure Am Heart J 149 363 369
25. TJ Wang MG Larson D Levy EJ Benjamin EP Leip T Omland 2004 Plasma natriuretic peptide levels and the risk of cardiovascular events and death N Engl J Med 350 655 663
26. G Bodlaj J Berg G Biesenbach 2005 Diurnal variation of arterial stiffness and subendocardial perfusion noninvasively assessed using applanation tonometry in healthy young men Wien Klin Wochenschr 117 348 352
27. JP Goetze C Christoffersen M Perko H Arendrup JF Rehfeld J Kastrup 2003 Increased cardiac BNP expression associated with myocardial ischemia FASEB J 17 1105 1107
28. PA Could J D'Agostino HG Schneider DM Kaye 2006 Influence of atrial fibrillation on cardiac brain natriuretic peptide release during hemodynamic stress in heart failure Eur J Card Heart 8 263 269